Non-greasy finish. Water-resistant. Non-comedogenic.
Reduces pigment spots - Prevents photoaging - Protects
An anti-dark spot sun protection against photo-aging, recommended for dry skin.
MELASCREEN UV Rich cream SPF50+ is the first photoprotective treatment from Ducray Dermatological Laboratories to limit and reduce dark spots* caused by exposure to the sun.
This anti-dark spot sun cream contains innovative active ingredients including RONACARE AP®, which limits dark spots and protects from photo-aging and cell damage with anti-oxidant action** that is 100 times more powerful than VITAMIN E.
With a new patented filter system, MELASCREEN UV Rich cream SPF50+ provides maximum protection against the harmful effects of UVB and UVA.
New pleasant texture, non-greasy finish, dispensed by a dosing pump.
• CORRECTS and prevents the appearance of dark spots while helping to fade them
• PREVENTS the appearance of wrinkles and fights photo-aging
• PROVIDES maximum protection against UV rays and nourishes the skin with a melting texture and non-oily finish
*Clinical study of 59 subjects with melasma or lentigo, 2 applications per day and before every exposure to the sun, for 4 weeks. % satisfied.
**In-vitro test : % of cellular damage inhibited in keratinocytes irradiated by UVA.
Manufactured and packaged in an environmentally certified facility****
****According to ISO 14001 and/or 50001
Product manufactured and packaged in a factory with high social standards
Ducray is a brand of the Pierre Fabre Group, certified at the highest Exemplary level of AFNOR Certification’s Committed to CSR and Responsibility Europe labels, thus consolidating a long-standing commitment to contributing to sustainable development.
Does ...
• Apply evenly : 5 to 6 doses on the face, 9 to 10 doses on the neck and chest area, and 1 to 2 doses on the back of the hands
• Reapply every 2 hours in case of intense exposure
• Apply every day, all year round
Active ingredient known to help reduce dark spots
• 86% satisfaction : improves evenness of skin tone¹
• -87% : cell damage is reduced, thanks to RonaCare®AP²
¹Clinical study of 59 subjects with melasma or lentigo, 2 applications per day and before every exposure to the sun, for 4 weeks. % satisfied.
²In-vitro test : % of cellular damage inhibited in keratinocytes irradiated by UVA.
